New at CADTH — January 2018

Drug Reimbursement Recommendations

CADTH Common Drug Review

Read the following CDR Update to find out what’s happening in CDR:

• Issue 132 — Update on Revised Process for Biosimilars, and Clarification Regarding Eligibility Assessments for Resubmissions.
• Nusinersen (Spinraza): Spinal Muscular Atrophy

CADTH pan-Canadian Oncology Drug Review (pCODR)

• Nivolumab and Ipilimumab in combo (Opdivo and Yervoy in combo): Metastatic Melanoma

Cancer Drug Pipeline Information 
The Cancer Drug Pipeline Information for Patient Groups is updated each month.

Health Technology Management Products

Rapid Response

Reports completed in December.

Recent Summaries of Evidence With Critical Appraisals Include:

• PRECICE Intramedullary Limb Lengthening System: A Review of Clinical Effectiveness
• Indwelling Voice Prostheses for Adults Following Laryngectomy: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
• Alpha1-Proteinase Inhibitors for the Treatment of Alpha1-Antitrypsin Deficiency: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

CADTH Resources

Read the latest “Evidence Matters” column in Hospital News: “Weeding through the evidence on medical cannabis.”

Resources to Address the Opioid Crisis 
A Statement from Dr. Brian O’Rourke, CADTH President and CEO, “One Year Later — CADTH’s Commitment to the Opioid Crisis.”

Evidence Bundles 
Our evidence bundles centralize all our reports related to treating opioid use disorder and interventions (drug and non-drug) to manage pain:

• Opioid Evidence Bundle
• Pain Evidence Bundle.

News and Events

Job Opportunities 
CADTH is looking for prospective Knowledge Mobilization contractors to work with our team. Read more about this opportunity.

CADTH Webinar 
We are pleased to present a webinar on Thursday, February 1, 2018, from 10:00 a.m. to 11:00 a.m. PST (1:00 p.m. to 2:00 p.m. EST) entitled, Compliant Flooring to Prevent Fall-Related Injuries: A Scoping Review. The webinar will assist health care professionals from across Canada who are tasked with preventing fall-related injuries by providing synthesized evidence about the impact of compliant flooring. There is no fee to participate, but registration is required: cadth.ca/events/flooring.

2018 CADTH Symposium 
Registration is opening soon for our 2018 Symposium, which will be held in Halifax from April 15 to 17, 2018. We regularly update information and make announcements about special dates on our website. Be the first to know what’s new by subscribing to our Symposium newsletter.

2018 Recognition Awards 
Do you know a leader in health technology assessment or perhaps a rising star in the field? CADTH Recognition Awards nominations are due by Friday, January 19, 2018.

CADTH Lecture Series 
Save the Date! On Tuesday, February 27, 2018, we will be hosting Dr. Matthew Seftel, MBChB, MPH, FRCP, FRCPC, for his CADTH Lecture related to gene therapy. Dr. Seftel is Head of the Department of Medical Oncology and Hematology at CancerCare Manitoba and Associate Professor at the Section of Hematology/Oncology, Department of Internal Medicine, at the University of Manitoba. Stay tuned for more details and how to register. In the meantime, you can watch the recordings of our previous lectures.

Beyond CADTH

Health Quality Ontario (HQO) 
HQO is offering a Quality Rounds Ontario event, Leadership Panel Discussion Addressing Opioid Use in Ontario: Reducing Harm, and Improving Care on Thursday, January 18, 2018 in Toronto, from 12:00 p.m.to 1:00 p.m. EST. For those who cannot attend in person, you can register for the webinar.

Tell Us What You Think

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.